image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Forterra

April 2023

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • FORT
  • Price:
  • 203.5p
Brick manufacturer Forterra unveiled finals in line with revenues up 23% to £456m. EBIT increased 35% to £73m with eps up 50% to 26.0p. The dividend was raised by half to 14.7p as net debt (excluding leases) fell from £10m to £6m. With the UK supply of bricks in structural shortage and imports far more expensive due to onerous transport costs, this has allowed management to hike prices (up 50% cumulatively since the start of 2022) to cover rising costs with a further double digit one planned for 2023. Meanwhile, the new Desford factory, which adds 22% to existing capacity, is operational and was delivered within the £95m budget with first dispatches expected shortly. Desford’s EBITDA contribution is expected to ramp up to £25m by ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X